Shanghai Shenqi Pharmaceutical Investment Management Dividend
Dividend criteriumcontroles 2/6
Shanghai Shenqi Pharmaceutical Investment Management is a dividend paying company with a current yield of 1.3%.
Belangrijke informatie
1.3%
Dividendrendement
0.08%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | 1.4% |
| Toekomstig dividendrendement | n/a |
| Dividendgroei | 22.8% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | CN¥0.100 |
| Uitbetalingsratio | 106% |
Recente dividendupdates
Geen updates
Recent updates
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.'s (SHSE:600613) 26% Share Price Surge Not Quite Adding Up
Oct 21
Why Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Earnings Are Better Than They Seem
May 06Investor Optimism Abounds Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) But Growth Is Lacking
Apr 17Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: 600613 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Groeiend dividend: 600613's dividend payments have increased, but the company has only paid a dividend for 9 years.
Dividendrendement versus markt
| Shanghai Shenqi Pharmaceutical Investment Management Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (600613) | 1.3% |
| Markt onderkant 25% (CN) | 0.6% |
| Markt Top 25% (CN) | 2.2% |
| Gemiddelde industrie (Pharmaceuticals) | 1.7% |
| Analist prognose (600613) (tot 3 jaar) | n/a |
Opmerkelijk dividend: 600613's dividend (1.3%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Hoog dividend: 600613's dividend (1.3%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Winstuitkering aan aandeelhouders
Verdiendekking: With its high payout ratio (105.7%), 600613's dividend payments are not well covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: With its reasonably low cash payout ratio (26.6%), 600613's dividend payments are well covered by cash flows.